In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) was $0.51 for the day, down -4.16% from the previous closing price of $0.53. In other words, the price has decreased by -$4.16 from its previous closing price. On the day, 2.3 million shares were traded. RVPH stock price reached its highest trading level at $0.53 during the session, while it also had its lowest trading level at $0.5032.
Ratios:
Our analysis of RVPH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $2.
On September 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $12. On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.The Benchmark Company initiated its Speculative Buy rating on June 08, 2023, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 58265680 and an Enterprise Value of 45082424.
Stock Price History:
The Beta on a monthly basis for RVPH is 0.00, which has changed by -0.5350877 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $4.28, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -2.50%, while the 200-Day Moving Average is calculated to be -29.13%.
Shares Statistics:
RVPH traded an average of 9.51M shares per day over the past three months and 3283890 shares per day over the past ten days. A total of 115.06M shares are outstanding, with a floating share count of 109.15M. Insiders hold about 5.13% of the company’s shares, while institutions hold 8.81% stake in the company. Shares short for RVPH as of 1763078400 were 23072984 with a Short Ratio of 2.35, compared to 1760486400 on 22270955. Therefore, it implies a Short% of Shares Outstanding of 23072984 and a Short% of Float of 20.950001.
Earnings Estimates
A detailed examination of Reviva Pharmaceuticals Holdings Inc (RVPH) is currently in progress, with 5.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.04 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.28 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.26, with 7.0 analysts recommending between $0.0 and -$0.85.
